NEW YORK, Oct. 7, 2019 /PRNewswire/ —
There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases.Current study describes some of the recent advances in immunotherapy, mostly cancer.
Read the full report: https://www.reportlinker.com/p05821889/?utm_source=PRN
These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies.Some of exciting technologies like trispecific and multispecific fusion proteins and antibody derivatives are also covered.
Combination of various immunotherpy approaches with / without modification and some of the unique approaches like photoimmunotherapy, RNA therapy, synthetic oncolytic viruses and latest artificial intelligence based platforms to develop neoantigens, peptide vaccines are discussed.
Read the full report: https://www.reportlinker.com/p05821889/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
The United States reveals the identity of and imposes sanctions on Dmitry Khoroshev, a senior…
As Prepared for DeliveryGood morning. I am very glad to welcome all of you to…
WASHINGTON—Acting Comptroller of the Currency Michael J. Hsu today issued the following statement supporting an…
Washington, D.C.— The Federal Deposit Insurance Corporation (FDIC), the Office of the Comptroller of the…
As Prepared for DeliveryI. IntroductionThank you to everyone for being here. It’s good to be…
Federal bank regulatory agencies today released a guide to support community banks in managing risks…